Description:

NCT01275664 Fast Fact Sheet for Protocol 0272 (Ovary, Fallopian Tube, Primary Peritoneal) Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9B7A8945-C35E-FFEC-E040-BB89AD43462D

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9B7A8945-C35E-FFEC-E040-BB89AD43462D

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 7/3/15
Uploaded on:

July 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NCT01275664 Fast Fact Sheet for Protocol 0272 (Ovary, Fallopian Tube, Primary Peritoneal)

No Instruction available.

  1. StudyEvent: Fast Fact Sheet for Protocol 0272 (Ovary, Fallopian Tube, Primary Peritoneal)
    1. No Instruction available.
Patient demographics
Miscellaneous Patient Information
Did the patient sign an approved informed consent
Has HIPAA authorization been obtained?
Has the patient enrolled in this study 48 hours or more in advance of starting treatment on cycle 1 on GOG-0252?
Which arm has the patient been randomized to on GOG-0252?
What is the primary disease site
Is the patient able to understand and read English?
Is the patient able to complete assessments?
Is the patient able to comply with anti-emetic therapy?
Has the patient met the pre-entry requirements as specified in section 7.0
Is the patient known to be hypersensitive to aprepitant, granisetron or any kind of the components of the patch or to dexamethasone?
In the treating physician's opinion, does the patient have a medical condition, or currently take medications, which are felt to contraindicate safe or effective administration of the standard three drug anti-emetic regimen used in this study?
Comments

Similar models